Beta‐blockers for hypertension
Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …
Calcium channel blockers versus other classes of drugs for hypertension
J Zhu, N Chen, M Zhou, J Guo, C Zhu… - Cochrane Database …, 2021 - cochranelibrary.com
Background This is the first update of a review published in 2010. While calcium channel
blockers (CCBs) are often recommended as a first‐line drug to treat hypertension, the effect …
blockers (CCBs) are often recommended as a first‐line drug to treat hypertension, the effect …
The risk of myocardial infarction associated with antihypertensive drug therapies
BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick… - Jama, 1995 - jamanetwork.com
Objective.—To assess the association between first myocardial infarction and the use of
antihypertensive agents. Design and Setting.—We conducted a population-based case …
antihypertensive agents. Design and Setting.—We conducted a population-based case …
Hypertension: management in adults in primary care: pharmacological update
National Collaborating Centre for Chronic Conditions … - 2006 - books.google.com
This rapid update of the NICE guideline on hypertension in primary care was undertaken
because recent large clinical outcome trials had provided new information about the …
because recent large clinical outcome trials had provided new information about the …
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
JMS JULIUS - Blood Pressure, 1998 - Taylor & Francis
Essential hypertension is a major Public Health issue. Although the number of treated
hypertensive patients has increased, only 25% of treated patients have their blood pressure …
hypertensive patients has increased, only 25% of treated patients have their blood pressure …
Advancing management of hypertension through pharmacogenomics
JA Johnson - Annals of medicine, 2012 - Taylor & Francis
Hypertension is the most common, chronic disease in the world, and there are many
effective pharmacological agents available for its treatment. Despite the plethora of …
effective pharmacological agents available for its treatment. Despite the plethora of …
[HTML][HTML] IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem …
VJ van den Berg, DO Haskard, A Fedorowski… - …, 2018 - thelancet.com
Abstract Background Certain immunoglobulins (Ig) are proposed to have protective
functions in atherosclerosis. Objectives We tested whether serum levels of IgG and IgM …
functions in atherosclerosis. Objectives We tested whether serum levels of IgG and IgM …
Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide
This study aimed to identify novel loci influencing the antihypertensive response to
hydrochlorothiazide monotherapy. A genome-wide meta-analysis of blood pressure (BP) …
hydrochlorothiazide monotherapy. A genome-wide meta-analysis of blood pressure (BP) …
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study
SE Kjeldsen, T Hedner, JO Syvertsen… - Journal of …, 2002 - journals.lww.com
Background The aim of the Nordic Diltiazem (NORDIL) Study was to compare patients with
essential hypertension receiving calcium-antagonist-based treatment with diltiazem and …
essential hypertension receiving calcium-antagonist-based treatment with diltiazem and …
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational study
O Samuelsson, K Pennert, O Andersson, G Berglund… - Bmj, 1996 - bmj.com
Objective: To analyse whether metabolic changes during long term treatment with
antihypertensive drugs are associated with an increased risk of coronary heart disease …
antihypertensive drugs are associated with an increased risk of coronary heart disease …